Literature DB >> 25138210

Idiopathic normal pressure hydrocephalus: cerebral perfusion measured with pCASL before and repeatedly after CSF removal.

Johan Virhammar1, Katarina Laurell2, André Ahlgren3, Kristina Giuliana Cesarini4, Elna-Marie Larsson5.   

Abstract

Pseudo-continuous arterial spin labeling (pCASL) measurements were performed in 20 patients with idiopathic normal pressure hydrocephalus (iNPH) to investigate whether cerebral blood flow (CBF) increases during the first 24 hours after a cerebrospinal fluid tap test (CSF TT). Five pCASL magnetic resonance imaging (MRI) scans were performed. Two scans were performed before removal of 40 mL CSF, and the other three at 30 minutes, 4 hours, and 24 hours, respectively after the CSF TT. Thirteen different regions of interest (ROIs) were manually drawn on coregistered MR images. In patients with increased CBF in lateral and frontal white matter after the CSF TT, gait function improved more than it did in patients with decreased CBF in these regions. However, in the whole sample, there was no significant increase in CBF after CSF removal compared with baseline investigations. The repeatability of CBF measurements at baseline was high, with intraclass correlation coefficients of 0.60 to 0.90 for different ROIs, but the median regional variability was in the range of 5% to 17%. Our results indicate that CBF in white matter close to the lateral ventricles plays a role in the reversibility of symptoms after CSF removal in patients with iNPH.

Entities:  

Mesh:

Year:  2014        PMID: 25138210      PMCID: PMC4269752          DOI: 10.1038/jcbfm.2014.138

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

1.  SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME.

Authors:  R D ADAMS; C M FISHER; S HAKIM; R G OJEMANN; W H SWEET
Journal:  N Engl J Med       Date:  1965-07-15       Impact factor: 91.245

2.  Voxel-based assessment of spinal tap test-induced regional cerebral blood flow changes in normal pressure hydrocephalus.

Authors:  Nicolas E Dumarey; Nicolas Massager; Steven Laureys; Serge Goldman
Journal:  Nucl Med Commun       Date:  2005-09       Impact factor: 1.690

3.  Cerebral perfusion measured by dynamic susceptibility contrast MRI is reduced in patients with idiopathic normal pressure hydrocephalus.

Authors:  Doerthe Ziegelitz; Göran Starck; David Kristiansen; Martin Jakobsson; Maria Hultenmo; Irene K Mikkelsen; Per Hellström; Mats Tullberg; Carsten Wikkelsø
Journal:  J Magn Reson Imaging       Date:  2013-09-04       Impact factor: 4.813

4.  The European iNPH Multicentre Study on the predictive values of resistance to CSF outflow and the CSF Tap Test in patients with idiopathic normal pressure hydrocephalus.

Authors:  Carsten Wikkelsø; Per Hellström; Petra Margarete Klinge; Jos Th J Tans
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-12-18       Impact factor: 10.154

5.  Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients.

Authors:  V Leinonen; J O Rinne; K A Virtanen; O Eskola; J Rummukainen; J Huttunen; M von Und Zu Fraunberg; O Nerg; A M Koivisto; J Rinne; J E Jääskeläinen; C Buckley; A Smith; P A Jones; P Sherwin; G Farrar; R McLain; M Kailajärvi; K Heurling; I D Grachev
Journal:  Eur J Neurol       Date:  2013-02-11       Impact factor: 6.089

6.  Global cerebral hypoperfusion in preclinical stage of idiopathic normal pressure hydrocephalus.

Authors:  Masahiko Takaya; Hiroaki Kazui; Hiromasa Tokunaga; Tetsuhiko Yoshida; Yumiko Kito; Tamiki Wada; Keiko Nomura; Eku Shimosegawa; Jun Hatazawa; Masatoshi Takeda
Journal:  J Neurol Sci       Date:  2010-09-22       Impact factor: 3.181

7.  Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease.

Authors:  Karlijn F de Laat; Anil M Tuladhar; Anouk G W van Norden; David G Norris; Marcel P Zwiers; Frank-Erik de Leeuw
Journal:  Brain       Date:  2010-12-14       Impact factor: 13.501

8.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

9.  Normal pressure hydrocephalus and cerebral blood flow: a PET study of baseline values.

Authors:  Brian K Owler; Shahan Momjian; Zofia Czosnyka; Marek Czosnyka; Alonso Péna; Neil G Harris; Piotr Smielewski; Tim Fryer; Tim Donovan; Jonathon Coles; Adrian Carpenter; John D Pickard
Journal:  J Cereb Blood Flow Metab       Date:  2004-01       Impact factor: 6.200

10.  Measurement of cerebral white matter perfusion using pseudocontinuous arterial spin labeling 3T magnetic resonance imaging--an experimental and theoretical investigation of feasibility.

Authors:  Wen-Chau Wu; Shu-Chi Lin; Danny J Wang; Kuan-Lin Chen; Ying-Ding Li
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more
  12 in total

1.  Pre-and postoperative cerebral blood flow changes in patients with idiopathic normal pressure hydrocephalus measured by computed tomography (CT)-perfusion.

Authors:  Doerthe Ziegelitz; Jonathan Arvidsson; Per Hellström; Mats Tullberg; Carsten Wikkelsø; Göran Starck
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

Review 2.  Interplay between vascular hemodynamics and the glymphatic system in the pathogenesis of idiopathic normal pressure hydrocephalus, exploring novel neuroimaging diagnostics.

Authors:  Sauson Soldozy; Kaan Yağmurlu; Jeyan Kumar; Turki Elarjani; Josh Burks; Aria Jamshidi; Evan Luther; Kenneth C Liu; Carolina G Benjamin; Robert M Starke; Min S Park; Hasan R Syed; Mark E Shaffrey; Ricardo J Komotar
Journal:  Neurosurg Rev       Date:  2021-11-13       Impact factor: 3.042

Review 3.  MR assessment of pediatric hydrocephalus: a road map.

Authors:  Charles Raybaud
Journal:  Childs Nerv Syst       Date:  2015-09-04       Impact factor: 1.475

4.  Association between the Onset of Idiopathic Normal Pressure Hydrocephalus Symptoms and Reduced Default Mode Network Connectivity.

Authors:  Koichi Miyazaki; Kohei Hanaoka; Hayato Kaida; Yasutaka Chiba; Kazunari Ishii
Journal:  Dement Geriatr Cogn Disord       Date:  2020-08-19       Impact factor: 2.959

5.  MRI assessment of the effects of acetazolamide and external lumbar drainage in idiopathic normal pressure hydrocephalus.

Authors:  Milos Ivkovic; Martin Reiss-Zimmermann; Heather Katzen; Matthias Preuss; Ilhami Kovanlikaya; Linda Heier; Noam Alperin; Karl T Hoffmann; Norman Relkin
Journal:  Fluids Barriers CNS       Date:  2015-04-02

6.  Idiopathic Normal Pressure Hydrocephalus: A Review for General Practitioners.

Authors:  Basant R Nassar; Carol F Lippa
Journal:  Gerontol Geriatr Med       Date:  2016-04-20

7.  Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging Demonstrates Reduced Periventricular Cerebral Blood Flow in Dogs with Ventriculomegaly.

Authors:  Martin J Schmidt; Malgorzata Kolecka; Robert Kirberger; Antje Hartmann
Journal:  Front Vet Sci       Date:  2017-08-22

8.  Parkinsonian symptoms in normal pressure hydrocephalus: a population-based study.

Authors:  Karin Molde; Lars Söderström; Katarina Laurell
Journal:  J Neurol       Date:  2017-09-06       Impact factor: 4.849

9.  Alteration of Venous Drainage Route in Idiopathic Normal Pressure Hydrocephalus and Normal Aging.

Authors:  Takeshi Satow; Toshihiko Aso; Sei Nishida; Taro Komuro; Tsukasa Ueno; Naoya Oishi; Yukako Nakagami; Masashi Odagiri; Takayuki Kikuchi; Kazumichi Yoshida; Keita Ueda; Takeharu Kunieda; Toshiya Murai; Susumu Miyamoto; Hidenao Fukuyama
Journal:  Front Aging Neurosci       Date:  2017-11-23       Impact factor: 5.750

10.  A venous mechanism of ventriculomegaly shared between traumatic brain injury and normal ageing.

Authors:  Toshihiko Aso; Genichi Sugihara; Toshiya Murai; Shiho Ubukata; Shin-Ichi Urayama; Tsukasa Ueno; Gaku Fujimoto; Dinh Ha Duy Thuy; Hidenao Fukuyama; Keita Ueda
Journal:  Brain       Date:  2020-06-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.